The myofibroblast in wound healing and fibrosis: answered and unanswered questions

F1000Res. 2016 Apr 26:5:F1000 Faculty Rev-752. doi: 10.12688/f1000research.8190.1. eCollection 2016.

Abstract

The discovery of the myofibroblast has allowed definition of the cell responsible for wound contraction and for the development of fibrotic changes. This review summarizes the main features of the myofibroblast and the mechanisms of myofibroblast generation. Myofibroblasts originate from a variety of cells according to the organ and the type of lesion. The mechanisms of myofibroblast contraction, which appear clearly different to those of smooth muscle cell contraction, are described. Finally, we summarize the possible strategies in order to reduce myofibroblast activities and thus influence several pathologies, such as hypertrophic scars and organ fibrosis.

Keywords: Myofibroblast; hypertrophic scars; mechanotransduction; myofibroblast contraction; myofibroblast generation; organ fibroses.

Publication types

  • Review

Grants and funding

The research of BH is supported by Canadian Institutes of Health Research (CIHR) (grants #210820, #286920, #286720, and #497202), the Collaborative Health Research Programme (CIHR/NSERC) (grants #1004005 and #413783), and the Canada Foundation for Innovation and Ontario Research Fund (CFI/ORF) (grant #26653). The research of MLBP is supported by the Swiss National Science Foundation (grant #146790/1).